Pulmonary veno-occlusive disease
…, X Jaďs, L Savale, F Perros, E Nossent… - European …, 2016 - Eur Respiratory Soc
Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension (PH)
characterised by preferential remodelling of the pulmonary venules. In the current PH …
characterised by preferential remodelling of the pulmonary venules. In the current PH …
Divergent SARS‐CoV‐2‐specific T‐and B‐cell responses in severe but not mild COVID‐19 patients
…, NAM Kragten, BM Hogema, EJ Nossent… - European journal of …, 2020 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the causative agent of
the current coronavirus disease 2019 (COVID‐19) pandemic. Understanding the immune …
the current coronavirus disease 2019 (COVID‐19) pandemic. Understanding the immune …
[HTML][HTML] Clinical features and prognostic factors in Covid-19: a prospective cohort study
…, EHT Lim, N van Mourik, J Nellen, EJ Nossent… - …, 2021 - thelancet.com
Background Mortality rates are high among hospitalized patients with COVID-19, especially
in those intubated on the ICU. Insight in pathways associated with unfavourable outcome …
in those intubated on the ICU. Insight in pathways associated with unfavourable outcome …
[HTML][HTML] Outcomes of hypofractionated high-dose radiotherapy in poor-risk patients with “ultracentral” non–small cell lung cancer
…, W Verbakel, E Bongers, S Hashemi, E Nossent… - Journal of Thoracic …, 2016 - Elsevier
Introduction We defined “ultracentral” lung tumors as centrally located non–small cell lung
cancers with planning target volumes overlapping the trachea or main bronchi. Increased …
cancers with planning target volumes overlapping the trachea or main bronchi. Increased …
Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses
P Trip, EJ Nossent, FS de Man… - European …, 2013 - Eur Respiratory Soc
A subgroup of patients with idiopathic pulmonary arterial hypertension (IPAH) has severely
reduced diffusing capacity of the lung for carbon monoxide (D LCO ) and poor prognosis. …
reduced diffusing capacity of the lung for carbon monoxide (D LCO ) and poor prognosis. …
Treatment-related toxicity in patients with early-stage non-small cell lung cancer and coexisting interstitial lung disease: a systematic review
Purpose Definitive treatment for patients with early-stage non-small cell lung cancer (ES-NSCLC)
is usually well tolerated. Patients with ES-NSCLC and coexisting interstitial lung …
is usually well tolerated. Patients with ES-NSCLC and coexisting interstitial lung …
Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19
A Saris, TDY Reijnders, EJ Nossent, AR Schuurman… - Thorax, 2021 - thorax.bmj.com
Background Knowledge of the pathophysiology of COVID-19 is almost exclusively derived
from studies that examined the immune response in blood. We here aimed to analyse the …
from studies that examined the immune response in blood. We here aimed to analyse the …
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
…, M Muller, ECW Neefjes, EJ Nossent… - The Lancet …, 2021 - thelancet.com
Background The major complication of COVID-19 is hypoxaemic respiratory failure from
capillary leak and alveolar oedema. Experimental and early clinical data suggest that the …
capillary leak and alveolar oedema. Experimental and early clinical data suggest that the …
[HTML][HTML] Indoleamine 2, 3‐dioxygenase (IDO)‐1 and IDO‐2 activity and severe course of COVID‐19
COVID‐19 is a pandemic with high morbidity and mortality. In an autopsy cohort of COVID‐19
patients, we found extensive accumulation of the tryptophan degradation products 3‐…
patients, we found extensive accumulation of the tryptophan degradation products 3‐…
[HTML][HTML] CD169 defines activated CD14+ monocytes with enhanced CD8+ T cell activation capacity
…, E Rodríguez, A Saris, ES Zwart, EJ Nossent… - Frontiers in …, 2021 - frontiersin.org
Monocytes are antigen-presenting cells (APCs) that play diverse roles in promoting or
regulating inflammatory responses, but their role in T cell stimulation is not well defined. In …
regulating inflammatory responses, but their role in T cell stimulation is not well defined. In …